A unit of German drug and chemicals group Bayer AG aims to make an expanded plant in Indonesia an Asia-Pacific production base for consumer care products.
Hans-Josef Schill, president director of PT Bayer Indonesia, was quoted as saying by The Jakarta Post on Friday (7/9/07) that the expansion of the plant would allow the firm to gradually lift its annual production capacity to 2,000 tons of over-the-counter medication from 700 tons currently.
"The expansion will allow the company to gradually increase its production capacity to up to 2,000 tons by 2012 for the domestic and regional markets," Schill told reporters after the inauguration of the expanded plant in Cimanggis, West Java.
Bayer Indonesia, which mostly produces pharmaceutical and over-the-counter drugs, said the expanded plant was acquired from the Indonesian unit of Swiss pharmaceutical company Roche.
Schill said the plant would produce consumer brands for the local market and countries in the region, including Malaysia, South Korea, Taiwan, China, Hong Kong and Australia.
Part of the production would also be exported to France. Bayer Indonesia expected the expansion to allow the company to increase exports 7.5-fold by 2010, from Rp20 billion to Rp25 billion ($2.13 million to $2.66 million) in 2005.